This report aims to provide a comprehensive presentation of the global market for Insomnia Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Therapy. This report contains market size and forecasts of Insomnia Therapy in global, including the following market information:
Global Insomnia Therapy Market Revenue, 2019-2024, 2024-2029, ($ millions)
Global top five companies in 2023 (%)
The global Insomnia Therapy market was valued at US$ million in 2023 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Non-pharmacological Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Insomnia Therapy include Merck & Co., Sanofi, Pfizer, Takeda Pharmaceutical Company Ltd., Purdue Pharmaceuticals L.P., Eisai, Co. Ltd., Meda Consumer Healthcare, Pernix Therapeutics and Vanda Pharmaceuticals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Insomnia Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Insomnia Therapy Market, by Type, 2019-2024, 2024-2029 ($ millions)
Global Insomnia Therapy Market Segment Percentages, by Type, 2023 (%)
Non-pharmacological Therapy
Pharmacological Therapy
Global Insomnia Therapy Market, by Application, 2019-2024, 2024-2029 ($ millions)
Global Insomnia Therapy Market Segment Percentages, by Application, 2023 (%)
Hospital
Ambulatory Surgical Center
Home Care
Global Insomnia Therapy Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions)
Global Insomnia Therapy Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Insomnia Therapy revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Insomnia Therapy revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Insomnia Therapy, market overview.
Chapter 2: Global Insomnia Therapy market size in revenue.
Chapter 3: Detailed analysis of Insomnia Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Insomnia Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Insomnia Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insomnia Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Insomnia Therapy Overall Market Size
2.1 Global Insomnia Therapy Market Size: 2022 VS 2031
2.2 Global Insomnia Therapy Market Size, Prospects & Forecasts: 2019-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Insomnia Therapy Players in Global Market
3.2 Top Global Insomnia Therapy Companies Ranked by Revenue
3.3 Global Insomnia Therapy Revenue by Companies
3.4 Top 3 and Top 5 Insomnia Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Insomnia Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Insomnia Therapy Players in Global Market
3.6.1 List of Global Tier 1 Insomnia Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Insomnia Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Insomnia Therapy Market Size Markets, 2022 & 2031
4.1.2 Non-pharmacological Therapy
4.1.3 Pharmacological Therapy
4.2 By Type - Global Insomnia Therapy Revenue & Forecasts
4.2.1 By Type - Global Insomnia Therapy Revenue, 2019-2024
4.2.2 By Type - Global Insomnia Therapy Revenue, 2024-2031
4.2.3 By Type - Global Insomnia Therapy Revenue Market Share, 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Insomnia Therapy Market Size, 2022 & 2031
5.1.2 Hospital
5.1.3 Ambulatory Surgical Center
5.1.4 Home Care
5.2 By Application - Global Insomnia Therapy Revenue & Forecasts
5.2.1 By Application - Global Insomnia Therapy Revenue, 2019-2024
5.2.2 By Application - Global Insomnia Therapy Revenue, 2024-2031
5.2.3 By Application - Global Insomnia Therapy Revenue Market Share, 2019-2031
6 Sights by Region
6.1 By Region - Global Insomnia Therapy Market Size, 2022 & 2031
6.2 By Region - Global Insomnia Therapy Revenue & Forecasts
6.2.1 By Region - Global Insomnia Therapy Revenue, 2019-2024
6.2.2 By Region - Global Insomnia Therapy Revenue, 2024-2031
6.2.3 By Region - Global Insomnia Therapy Revenue Market Share, 2019-2031
6.3 North America
6.3.1 By Country - North America Insomnia Therapy Revenue, 2019-2031
6.3.2 US Insomnia Therapy Market Size, 2019-2031
6.3.3 Canada Insomnia Therapy Market Size, 2019-2031
6.3.4 Mexico Insomnia Therapy Market Size, 2019-2031
6.4 Europe
6.4.1 By Country - Europe Insomnia Therapy Revenue, 2019-2031
6.4.2 Germany Insomnia Therapy Market Size, 2019-2031
6.4.3 France Insomnia Therapy Market Size, 2019-2031
6.4.4 U.K. Insomnia Therapy Market Size, 2019-2031
6.4.5 Italy Insomnia Therapy Market Size, 2019-2031
6.4.6 Russia Insomnia Therapy Market Size, 2019-2031
6.4.7 Nordic Countries Insomnia Therapy Market Size, 2019-2031
6.4.8 Benelux Insomnia Therapy Market Size, 2019-2031
6.5 Asia
6.5.1 By Region - Asia Insomnia Therapy Revenue, 2019-2031
6.5.2 China Insomnia Therapy Market Size, 2019-2031
6.5.3 Japan Insomnia Therapy Market Size, 2019-2031
6.5.4 South Korea Insomnia Therapy Market Size, 2019-2031
6.5.5 Southeast Asia Insomnia Therapy Market Size, 2019-2031
6.5.6 India Insomnia Therapy Market Size, 2019-2031
6.6 South America
6.6.1 By Country - South America Insomnia Therapy Revenue, 2019-2031
6.6.2 Brazil Insomnia Therapy Market Size, 2019-2031
6.6.3 Argentina Insomnia Therapy Market Size, 2019-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Insomnia Therapy Revenue, 2019-2031
6.7.2 Turkey Insomnia Therapy Market Size, 2019-2031
6.7.3 Israel Insomnia Therapy Market Size, 2019-2031
6.7.4 Saudi Arabia Insomnia Therapy Market Size, 2019-2031
6.7.5 UAE Insomnia Therapy Market Size, 2019-2031
7 Insomnia Therapy Companies Profiles
7.1 Merck & Co.
7.1.1 Merck & Co. Company Summary
7.1.2 Merck & Co. Business Overview
7.1.3 Merck & Co. Insomnia Therapy Major Product Offerings
7.1.4 Merck & Co. Insomnia Therapy Revenue in Global Market (2019-2024)
7.1.5 Merck & Co. Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Insomnia Therapy Major Product Offerings
7.2.4 Sanofi Insomnia Therapy Revenue in Global Market (2019-2024)
7.2.5 Sanofi Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Insomnia Therapy Major Product Offerings
7.3.4 Pfizer Insomnia Therapy Revenue in Global Market (2019-2024)
7.3.5 Pfizer Key News & Latest Developments
7.4 Takeda Pharmaceutical Company Ltd.
7.4.1 Takeda Pharmaceutical Company Ltd. Company Summary
7.4.2 Takeda Pharmaceutical Company Ltd. Business Overview
7.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Major Product Offerings
7.4.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue in Global Market (2019-2024)
7.4.5 Takeda Pharmaceutical Company Ltd. Key News & Latest Developments
7.5 Purdue Pharmaceuticals L.P.
7.5.1 Purdue Pharmaceuticals L.P. Company Summary
7.5.2 Purdue Pharmaceuticals L.P. Business Overview
7.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Major Product Offerings
7.5.4 Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue in Global Market (2019-2024)
7.5.5 Purdue Pharmaceuticals L.P. Key News & Latest Developments
7.6 Eisai, Co. Ltd.
7.6.1 Eisai, Co. Ltd. Company Summary
7.6.2 Eisai, Co. Ltd. Business Overview
7.6.3 Eisai, Co. Ltd. Insomnia Therapy Major Product Offerings
7.6.4 Eisai, Co. Ltd. Insomnia Therapy Revenue in Global Market (2019-2024)
7.6.5 Eisai, Co. Ltd. Key News & Latest Developments
7.7 Meda Consumer Healthcare
7.7.1 Meda Consumer Healthcare Company Summary
7.7.2 Meda Consumer Healthcare Business Overview
7.7.3 Meda Consumer Healthcare Insomnia Therapy Major Product Offerings
7.7.4 Meda Consumer Healthcare Insomnia Therapy Revenue in Global Market (2019-2024)
7.7.5 Meda Consumer Healthcare Key News & Latest Developments
7.8 Pernix Therapeutics
7.8.1 Pernix Therapeutics Company Summary
7.8.2 Pernix Therapeutics Business Overview
7.8.3 Pernix Therapeutics Insomnia Therapy Major Product Offerings
7.8.4 Pernix Therapeutics Insomnia Therapy Revenue in Global Market (2019-2024)
7.8.5 Pernix Therapeutics Key News & Latest Developments
7.9 Vanda Pharmaceuticals
7.9.1 Vanda Pharmaceuticals Company Summary
7.9.2 Vanda Pharmaceuticals Business Overview
7.9.3 Vanda Pharmaceuticals Insomnia Therapy Major Product Offerings
7.9.4 Vanda Pharmaceuticals Insomnia Therapy Revenue in Global Market (2019-2024)
7.9.5 Vanda Pharmaceuticals Key News & Latest Developments
7.10 ECR Pharmaceuticals
7.10.1 ECR Pharmaceuticals Company Summary
7.10.2 ECR Pharmaceuticals Business Overview
7.10.3 ECR Pharmaceuticals Insomnia Therapy Major Product Offerings
7.10.4 ECR Pharmaceuticals Insomnia Therapy Revenue in Global Market (2019-2024)
7.10.5 ECR Pharmaceuticals Key News & Latest Developments
7.11 Fidia Farmaceutici
7.11.1 Fidia Farmaceutici Company Summary
7.11.2 Fidia Farmaceutici Business Overview
7.11.3 Fidia Farmaceutici Insomnia Therapy Major Product Offerings
7.11.4 Fidia Farmaceutici Insomnia Therapy Revenue in Global Market (2019-2024)
7.11.5 Fidia Farmaceutici Key News & Latest Developments
7.12 Dainippon Sumitomo
7.12.1 Dainippon Sumitomo Company Summary
7.12.2 Dainippon Sumitomo Business Overview
7.12.3 Dainippon Sumitomo Insomnia Therapy Major Product Offerings
7.12.4 Dainippon Sumitomo Insomnia Therapy Revenue in Global Market (2019-2024)
7.12.5 Dainippon Sumitomo Key News & Latest Developments
7.13 Biocodex
7.13.1 Biocodex Company Summary
7.13.2 Biocodex Business Overview
7.13.3 Biocodex Insomnia Therapy Major Product Offerings
7.13.4 Biocodex Insomnia Therapy Revenue in Global Market (2019-2024)
7.13.5 Biocodex Key News & Latest Developments
7.14 Eli Lilly and Company
7.14.1 Eli Lilly and Company Company Summary
7.14.2 Eli Lilly and Company Business Overview
7.14.3 Eli Lilly and Company Insomnia Therapy Major Product Offerings
7.14.4 Eli Lilly and Company Insomnia Therapy Revenue in Global Market (2019-2024)
7.14.5 Eli Lilly and Company Key News & Latest Developments
7.15 Ebb Therapeutics
7.15.1 Ebb Therapeutics Company Summary
7.15.2 Ebb Therapeutics Business Overview
7.15.3 Ebb Therapeutics Insomnia Therapy Major Product Offerings
7.15.4 Ebb Therapeutics Insomnia Therapy Revenue in Global Market (2019-2024)
7.15.5 Ebb Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Insomnia Therapy Market Opportunities & Trends in Global Market
Table 2. Insomnia Therapy Market Drivers in Global Market
Table 3. Insomnia Therapy Market Restraints in Global Market
Table 4. Key Players of Insomnia Therapy in Global Market
Table 5. Top Insomnia Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Insomnia Therapy Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Insomnia Therapy Revenue Share by Companies, 2019-2024
Table 8. Global Companies Insomnia Therapy Product Type
Table 9. List of Global Tier 1 Insomnia Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insomnia Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Insomnia Therapy Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Insomnia Therapy Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Insomnia Therapy Revenue in Global (US$, Mn), 2024-2031
Table 14. By Application ? Global Insomnia Therapy Revenue, (US$, Mn), 2022 & 2031
Table 15. By Application - Insomnia Therapy Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Insomnia Therapy Revenue in Global (US$, Mn), 2024-2031
Table 17. By Region ? Global Insomnia Therapy Revenue, (US$, Mn), 2022 & 2031
Table 18. By Region - Global Insomnia Therapy Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Insomnia Therapy Revenue (US$, Mn), 2024-2031
Table 20. By Country - North America Insomnia Therapy Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Insomnia Therapy Revenue, (US$, Mn), 2024-2031
Table 22. By Country - Europe Insomnia Therapy Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Insomnia Therapy Revenue, (US$, Mn), 2024-2031
Table 24. By Region - Asia Insomnia Therapy Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Insomnia Therapy Revenue, (US$, Mn), 2024-2031
Table 26. By Country - South America Insomnia Therapy Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Insomnia Therapy Revenue, (US$, Mn), 2024-2031
Table 28. By Country - Middle East & Africa Insomnia Therapy Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Insomnia Therapy Revenue, (US$, Mn), 2024-2031
Table 30. Merck & Co. Company Summary
Table 31. Merck & Co. Insomnia Therapy Product Offerings
Table 32. Merck & Co. Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 33. Merck & Co. Key News & Latest Developments
Table 34. Sanofi Company Summary
Table 35. Sanofi Insomnia Therapy Product Offerings
Table 36. Sanofi Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 37. Sanofi Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Insomnia Therapy Product Offerings
Table 40. Pfizer Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 41. Pfizer Key News & Latest Developments
Table 42. Takeda Pharmaceutical Company Ltd. Company Summary
Table 43. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product Offerings
Table 44. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 45. Takeda Pharmaceutical Company Ltd. Key News & Latest Developments
Table 46. Purdue Pharmaceuticals L.P. Company Summary
Table 47. Purdue Pharmaceuticals L.P. Insomnia Therapy Product Offerings
Table 48. Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 49. Purdue Pharmaceuticals L.P. Key News & Latest Developments
Table 50. Eisai, Co. Ltd. Company Summary
Table 51. Eisai, Co. Ltd. Insomnia Therapy Product Offerings
Table 52. Eisai, Co. Ltd. Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 53. Eisai, Co. Ltd. Key News & Latest Developments
Table 54. Meda Consumer Healthcare Company Summary
Table 55. Meda Consumer Healthcare Insomnia Therapy Product Offerings
Table 56. Meda Consumer Healthcare Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 57. Meda Consumer Healthcare Key News & Latest Developments
Table 58. Pernix Therapeutics Company Summary
Table 59. Pernix Therapeutics Insomnia Therapy Product Offerings
Table 60. Pernix Therapeutics Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 61. Pernix Therapeutics Key News & Latest Developments
Table 62. Vanda Pharmaceuticals Company Summary
Table 63. Vanda Pharmaceuticals Insomnia Therapy Product Offerings
Table 64. Vanda Pharmaceuticals Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 65. Vanda Pharmaceuticals Key News & Latest Developments
Table 66. ECR Pharmaceuticals Company Summary
Table 67. ECR Pharmaceuticals Insomnia Therapy Product Offerings
Table 68. ECR Pharmaceuticals Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 69. ECR Pharmaceuticals Key News & Latest Developments
Table 70. Fidia Farmaceutici Company Summary
Table 71. Fidia Farmaceutici Insomnia Therapy Product Offerings
Table 72. Fidia Farmaceutici Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 73. Fidia Farmaceutici Key News & Latest Developments
Table 74. Dainippon Sumitomo Company Summary
Table 75. Dainippon Sumitomo Insomnia Therapy Product Offerings
Table 76. Dainippon Sumitomo Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 77. Dainippon Sumitomo Key News & Latest Developments
Table 78. Biocodex Company Summary
Table 79. Biocodex Insomnia Therapy Product Offerings
Table 80. Biocodex Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 81. Biocodex Key News & Latest Developments
Table 82. Eli Lilly and Company Company Summary
Table 83. Eli Lilly and Company Insomnia Therapy Product Offerings
Table 84. Eli Lilly and Company Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 85. Eli Lilly and Company Key News & Latest Developments
Table 86. Ebb Therapeutics Company Summary
Table 87. Ebb Therapeutics Insomnia Therapy Product Offerings
Table 88. Ebb Therapeutics Insomnia Therapy Revenue (US$, Mn) & (2019-2024)
Table 89. Ebb Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Insomnia Therapy Segment by Type in 2022
Figure 2. Insomnia Therapy Segment by Application in 2022
Figure 3. Global Insomnia Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Insomnia Therapy Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Insomnia Therapy Revenue, 2019-2031 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Insomnia Therapy Revenue in 2022
Figure 8. By Type - Global Insomnia Therapy Revenue Market Share, 2019-2031
Figure 9. By Application - Global Insomnia Therapy Revenue Market Share, 2019-2031
Figure 10. By Type - Global Insomnia Therapy Revenue, (US$, Mn), 2022 & 2031
Figure 11. By Type - Global Insomnia Therapy Revenue Market Share, 2019-2031
Figure 12. By Application - Global Insomnia Therapy Revenue, (US$, Mn), 2022 & 2031
Figure 13. By Application - Global Insomnia Therapy Revenue Market Share, 2019-2031
Figure 14. By Region - Global Insomnia Therapy Revenue Market Share, 2019-2031
Figure 15. By Country - North America Insomnia Therapy Revenue Market Share, 2019-2031
Figure 16. US Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 17. Canada Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 18. Mexico Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 19. By Country - Europe Insomnia Therapy Revenue Market Share, 2019-2031
Figure 20. Germany Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 21. France Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 22. U.K. Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 23. Italy Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 24. Russia Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 25. Nordic Countries Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 26. Benelux Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 27. By Region - Asia Insomnia Therapy Revenue Market Share, 2019-2031
Figure 28. China Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 29. Japan Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 30. South Korea Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 31. Southeast Asia Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 32. India Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 33. By Country - South America Insomnia Therapy Revenue Market Share, 2019-2031
Figure 34. Brazil Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 35. Argentina Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 36. By Country - Middle East & Africa Insomnia Therapy Revenue Market Share, 2019-2031
Figure 37. Turkey Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 38. Israel Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 39. Saudi Arabia Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 40. UAE Insomnia Therapy Revenue, (US$, Mn), 2019-2031
Figure 41. Merck & Co. Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Sanofi Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Pfizer Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Eisai, Co. Ltd. Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Meda Consumer Healthcare Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Pernix Therapeutics Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Vanda Pharmaceuticals Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. ECR Pharmaceuticals Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Fidia Farmaceutici Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Dainippon Sumitomo Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Biocodex Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Eli Lilly and Company Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Ebb Therapeutics Insomnia Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
